AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-134632202/genzyme-drug-gets-boost.html" title="Facts and information about Genzyme drug gets a boost.">Genzyme drug gets a boost.</a>

Close Set up an RSS feed that alerts you when new articles from The Boston Globe (Boston, MA) are available.

Frequently asked questions about RSS feeds

Genzyme drug gets a boost.

The Boston Globe (Boston, MA)

| July 29, 2005 | Heuser, Stephen | This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: Stephen Heuser

Jul. 29--Genzyme Corp. said yesterday its kidney dialysis drug Renagel cut the death rate in long-term dialysis patients and in patients over 65, according to a new study that compared Renagel to competing drugs.

Renagel, a pill for which the Cambridge biotech company charges $1,500 to $2,500 a year, helps dialysis patients flush the nutrient phosphate out of their systems before it can build up to dangerous levels.

A study of 2,103 patients compared those on Renagel -- based on a large, indigestible molecule called a polymer -- to patients on competing drugs based on calcium. Renagel's main competitor is a calcium-based pill…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Renagel[R]: A New and Different Phosphate Binder.: Magazine article from: ANNA Journal Ramsdell, Russ June 1, 1999 700+ words
...Burke, Goldberg, et al., 1997). Renagel[R] (sevelamer hydrochloride) is designed...Unlike currently available agents, Renagel does not contain calcium or aluminum that...Indications and Contraindications/Precautions Renagel capsules are indicated for the reduction...


Renagel in New Dialysis Study Published in Kidney International.: Press release article from: PR Newswire January 8, 2007 700+ words
Data Show That Patients Treated with Renagel Achieve Mortality Benefit CAMBRIDGE...International demonstrate that patients using Renagel experienced a significantly lower rate...study. The results were drawn from the Renagel in New Dialysis study (RIND), a randomized...


Renagel Study in New Dialysis Patients Published in Kidney International.: Press release article from: PR Newswire September 29, 2005 700+ words
Data Support Early Treatment with Renagel CAMBRIDGE, Mass., Sept. 29 /PRNewswire...announced today that results from the Renagel in New Dialysis (RIND) study have been...the RIND study compared the effects of Renagel(R) (sevelamer hydrochloride) with...


RENAGEL SIGNIFICANTLY SLOWS PROGRESSION OF CARDIAC CALCIFICATION; NEW STUDY...: Press release article from: PR Newswire June 26, 2001 700+ words
...progression of cardiac calcification when using Renagel(R) (sevelamer hydrochloride), a...their cardiac calcification scores, while Renagel patients experienced a non-significant...calcification compared to the patients who took Renagel." There are 300,000 dialysis patients...


EMEA Approves Renagel(R) Production at New Genzyme Plant in Ireland.: Press release article from: PR Newswire March 27, 2003 700+ words
...Agency has approved the production of Renagel(R) (sevelamer hydrochloride) tablets...capacity to support the worldwide growth of Renagel, a phosphate binder for patients with...renal disease who are on hemodialysis. Renagel is marketed by the Genzyme General division...


Genzyme Launches the Renagel REACH Program Expanding Access for Medicare...: Press release article from: PR Newswire September 20, 2004 700+ words
...today that it will enhance access to Renagel(R) (sevelamer hydrochloride...Medicare beneficiaries through the new Renagel REACH Program(SM), launched in...beneficiaries are eligible to receive Renagel for either $5 or $25 per month...


Genzyme General Receives Approval to Market Renagel(R) in Brazil.: Press release article from: PR Newswire August 15, 2001 700+ words
...that it has received approval to market Renagel(R) (sevelamer hydrochloride) in Brazil...obtain reimbursement authorization for Renagel and launch the product by the end of the...dedicated sales and marketing organization. Renagel is a phosphate binder for patients with...


GelTex, Genzyme Announce FDA Marketing Approval for Renagel(R) Capsules.: Press release article from: PR Newswire November 2, 1998 700+ words
...FDA) has granted marketing approval for Renagel(R) Capsules (sevelamer hydrochloride...ESRD). The safety and efficacy of Renagel Capsules in ESRD patients who are not...ESRD patients on dialysis in the U.S. Renagel is the first product to be approved that...


Genzyme General, GelTex Announce European Marketing Approval for Renagel.: Press release article from: PR Newswire February 3, 2000 700+ words
...granted marketing approval in Europe for Renagel(R) Capsules for the control of hyperphosphatemia...hemodialysis. Marketing authorization for Renagel is valid in the 15 member states of the European Union. Renagel received marketing approval in the United...


Genzyme, GelTex Announce FDA Approval to Market Renagel Tablets.: Press release article from: PR Newswire July 13, 2000 700+ words
...FDA) has granted marketing approval for Renagel(R) Tablets (sevelamer hydrochloride...patients with end-stage renal disease. Renagel is currently available in a 403 mg capsule form. The new tablet formulation of Renagel will provide physicians with two new dosing...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: